Focus on cancer curing

Corporate News

Fosun Kite’s Axicabtagene Ciloleucel Granted Priority Review by China NMPA


Corporate News

Fosun Kite’s New Drug Application (NDA) Filing for Axicabtagene Ciloleucel Accepted for Review by China NMPA


About Fosun Kite

Research, develop and license-in the world first class immuno cell therapies

Kite Pharma, a Gilead company, is a leader in engineered T cell therapy. Fosun Pharma is a strong healthcare industrial group in China with rich experiences from R&D to commercialization. This establishment between Kite and Fosun will bring the world first class immuno cell therapies to benefit patients in China.

Our Mission

Become a leader of innovation and industrialization in immuno cell therapy development

Join us